Inter-fraction motion robustness in a prospective phase II trial on dose-escalated proton reirradiation for locally recurrent rectal cancer von Truelsen, Christina G., Rønde, Heidi S., Kallehauge, Jesper F., Poulsen, Laurids Ø., Havelund, Birgitte M., Pedersen, Bodil G., Iversen, Lene H., Spindler, Karen-Lise G., Kronborg, Camilla S.

Volltext

479 Plasma is Superior to Serum for CfDNA Mutation Detection and Monitoring von Andersen, R.F, Spindler, K.G, Jakobsen, A, Pallisgaard, N

Volltext

471 KRAS, BRAF and PIK3Ca Mutations as Predictors of Outcome From Maintenance Therapy with Bevacizumab with or Without Erlotinib After First Line Combination Therapy for Metastatic... von Spindler, K.G, dePont Christensen, R, Andersen, R.F, Pallisgaard, N, Johnson, A, Jakobsen, A

Volltext

PO-1271 Dose-escalated pencil beam proton therapy for reirradiation of pelvic recurrences from rectal cancer von Kronborg, C., Rønde, H.S., Kallehauge, J.F., Guren, M.G., Spindler, K.G.

Volltext

6105 POSTER Phase II Trial of Temsirolimus Alone and in Combination With Irinotecan for KRas Mutant Chemotherapy Resistant Metastatic Colorectal Cancer and the Importance of KRas M... von Spindler, K.G, Sorensen, M, Pallisgaard, N, Andersen, R.F, Lassen, U, Havelund, B.M, Ploen, J, Jakobsen, A

Volltext

OC-0271 Hypoxia in anal cancer – a hypothesis generating study using a 15-gene hypoxia classifier von Lefèvre, A.C., Alsner, J., Sørensen, B.S., Tramm, T., Toustrup, K., Overgaard, J., Spindler, K.G.

Volltext

PO-1399 Bowel delineation methods and prediction of acute and late diarrhea in radiotherapy of anal cancer von Storm, K.S., Homburg, S., Persson, G.F., Behrens, C.P., Sibolt, P., Spindler, K.G., Kronborg, C., Serup-Hansen, E.

Volltext

EP-1469 Radiation dose to pelvic floor muscles and functional outcome after treatment for anal cancer von Kronborg, C., Christensen, P., Pedersen, B.G., Spindler, K.G.

Volltext

PH-0114 Pelvic insufficiency fractures detected by MRI one-year after chemoradiotherapy for anal cancer von Kronborg, C., Pedersen, B.G., Klemmensen, J., Lefévre, A.C., Wind, K.L., Spindler, K.G.

Volltext

OC-0619 Plasma HPV elimination patterns as strong predictor of outcome in primary Anal Cancer treatment von Lefèvre, A.C., Pallisgaard, N., Kronborg, C., Wind, K.L., Krag, S.N., Spindler, K.G.

Volltext

PD-0499 Bonesparing radiotherapy for anal cancer. -Initial planning quality for the DACG II trial von Kronborg, C., Nyvang, L., Hansen, J., Serup-Hansen, E., Havelund, B., Wilken, E., Mc Ilroy, S.P., Spindler, K.G.

Volltext

OC-0335: Circulating free DNA in squamous cell carcinoma of the anus: Relation to risk factors and recurrence von Lefèvre, A.C., Kronborg, C., Sørensen, B.S., Serup-Hansen, E., Spindler, K.G.

Volltext

216PCIRCULATING FREE DNA AND PLASMA KRAS MUTATIONS IN METASTATIC COLORECTAL CANCER PATIENTS TREATED WITH BI-WEEKLY CETUXIMAB AND IRINOTECAN von Spindler, K.G., Pallisgaard, N., Skovgaard, K., Andersen, R., Hendel, H., Yilmaz, M., Pfeiffer, P., Nielsen, D.L., Johansen, J., Hoegdall, E., Jakobsen, A., Vittrup, B.

Volltext

Circulating Free Dna and Plasma Kras Mutations in Metastatic Colorectal Cancer Patients Treated with Bi-Weekly Cetuximab and Irinotecan von Spindler, K.G., Pallisgaard, N., Skovgaard, K., Andersen, R., Hendel, H., Yilmaz, M., Pfeiffer, P., Nielsen, D.L., Johansen, J., Hoegdall, E., Jakobsen, A., Vittrup, B.

Volltext